Nanjing Biotech and pharmaceutical Valley
In March 2010, Nanjing Municipal Party Committee and Government decided to take the biomedical and pharmaceutical industry as a strategic emerging industry in Nanjing, and made it clear that the Nanjing Biotech and Pharmaceutical Valley(herein after “NJBPV”) would be built on the basis of the biomedical industry in the former plan laid out by Nanjing High Tech Zone, with the goal of building a biomedical R & D innovation and industrial base. In March 2011, NJBPV was officially approved to set up, and started regional planning and infrastructure construction. In February 2013, the building construction of 95000 square meters in the first phase started. In April 2015, the first phase of infrastructure construction was completed and delivered with an area of 95000 square meters, officially opening regional investment promotion and industrial development.
NJBPV is located at the foot of Longwang Mountain with beautiful natural view around. It is planned to start with the area of 14.92 square kilometers, where is divided into R&D area and manufacturing area. R&D area covers an area of 8.1 square kilometers, which centers on R & D innovation incubation and industrial chain of bio-medicine. The industrial chain runs through R & D incubation, pilot test, production, headquarters office and sales settlement. It has initially built professional incubation building, accelerator building, business office building, exhibition center, public technology platform for biomedical detection and analysis, animal experiment center, pilot scale-up platform for key technologies and other professional facilities. The software and hardware environment for biomedical R & D innovation, incubation, pilot scale-up, office, business exhibition and so on is increasingly improved. The manufacture area covers an area of 6.82 square kilometers. It is planned to be mainly used for the construction and production of innovative scale-up enterprises as well as supporting R & D, office and other comprehensive bases. In addition, the park also focuses on the construction of GMP compliant plants and GSP compliant pharmaceutical warehousing and logistics centers in the region to meet the needs of integration of R & D, production and office functions of fast-growing science and technology enterprises.
By the end of 2020, in R&D area, 900,000+ m2 of real estate such as incubator, accelerator, R & D headquarters building, business center, exhibition center and office building have been built and put in use in the R & D zone, and 400,000+ m2 are under construction. In manufacturing area, 200,000+ m2 of standard workshops and single building headquarters, and 160,000 square meters are under construction, to meet the demand of R & D, production, office and other integrated functions of fast-growing technology enterprises. By the end of 2020, 29 enterprises have settled in the industrial zone, and nearly 1.1 million square meters of comprehensive functional properties have been built.